Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Guggenheim Long Short Equity C RYISX
- NAV / 1-Day Return 19.45 / +0.67 %
- Total Assets 17.6 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.610%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Long-Short Equity
- Investment Style Mid Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield —
- Turnover 329%
USD | NAV as of Apr 22, 2024 | 1-Day Return as of Apr 22, 2024, 10:18 PM GMT+0
Morningstar’s Analysis RYISX
Will RYISX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings —
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Ms Equity Custom Basket | 5.55 | 857,923 | — |
Gs Equity Custom Basket | 5.51 | 852,048 | — |
Microsoft Corp | 1.81 | 279,774 | Technology |
Invesco Shrt-Trm Inv Trs Oblig Instl | 1.64 | 252,908 | Corporate |
Qualcomm Inc | 0.88 | 135,952 | Technology |
Merck & Co Inc | 0.86 | 132,568 | Healthcare |
Johnson & Johnson | 0.86 | 132,289 | Healthcare |
Toll Brothers Inc | 0.85 | 132,085 | Consumer Cyclical |
Visa Inc Class A | 0.85 | 131,997 | Financial Services |
Thermo Fisher Scientific Inc | 0.85 | 131,636 | Healthcare |